|
Volumn 19, Issue 3, 2001, Pages
|
New challenges in the disease management of hypertension
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIHYPERTENSIVE AGENT;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
CARDIOVASCULAR RISK;
DOSE RESPONSE;
DRUG EFFICACY;
EUROPE;
HUMAN;
HYPERTENSION;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
RISK FACTOR;
SHORT SURVEY;
TREATMENT PLANNING;
UNITED STATES;
BLOOD PRESSURE;
DRUG EFFECT;
EDITORIAL;
TREATMENT OUTCOME;
ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
ANTIHYPERTENSIVE AGENTS;
BLOOD PRESSURE;
DOSE-RESPONSE RELATIONSHIP, DRUG;
HUMANS;
HYPERTENSION;
TREATMENT OUTCOME;
UNITED STATES;
|
EID: 0035457894
PISSN: 09521178
EISSN: None
Source Type: Journal
DOI: None Document Type: Short Survey |
Times cited : (3)
|
References (0)
|